NOV 10, 2020 8:00 AM PST

Genetic Profiling Reveals How Ebola Puts Immune Cells in a Chokehold

WRITTEN BY: Tara Fernandez

In June of 2020, yet another deadly Ebola outbreak was reported in the Democratic Republic of the Congo - the 11th outbreak since the virus was first discovered in the mid-1970s. Ebola virus sits at the top of the list of the world’s deadliest viral pathogens which leaves its victims fighting for their lives with symptoms such as fever, diarrhea, and internal hemorrhaging. In a bid to control ongoing outbreaks of the disease, scientists are on the hunt for targeted and effective antiviral therapeutics.

Many of Ebola’s devastating effects are known to be due to its manipulation of the body’s immune system which enables the virus to multiply and wreak havoc on internal organs. In a recent study published in the journal Cell, scientists take a journey into the genetics of Ebola’s effects on the immune system, one cell at a time.

Researchers from MIT’s Broad Institute used single-cell RNA sequencing technology to piece the puzzle together, starting with a sample of around 100,000 immune cells harvested from rhesus monkeys that had been infected with Ebola. The goal was to create a map of genetic activity in these immune cells at different stages of infection. This would pave the way for new Ebola therapeutics that target the immune system to alleviate symptoms.

Aaron Lin, co-first author of the study explained: “Treating the immune system in a more targeted way I think is where new therapeutics need to go.” 

“Figuring out which branches of the immune system should be targeted can be informed by single-cell studies of infection and other kinds of analyses.” 

The team found that a particular subset of immune cells called monocytes was most affected by Ebola infection, with the virus turning off key genes required to stimulate an effective immune response in these cells. Monocytes, a type of white blood cell, are the largest type of leukocyte and can differentiate into a variety of other immune cells including macrophages and myeloid lineage dendritic cells. Lin and team demonstrated how the virus downregulated genes relating to class II antigen presentation in monocytes, a process that triggers antibody production and triggers the activation of helper T cells. Moreover, Ebola choked the cells’ ability to synthesize interferon — an immune molecule that sets off a powerful antiviral response.

“Previous studies of Ebola virus in cells in a dish had generated hints of how the virus affects the immune system, but with more data across the whole genome and better resolution at a single-cell level from a natural infection over time, we got a more complete picture of what the immune system looks like during infection,” said Dylan Kotliar, a co-first author of the publication.

 

Sources: Broad Institute, Cell.


 

About the Author
  • Tara Fernandez has a PhD in Cell Biology and has spent over a decade uncovering the molecular basis of diseases ranging from skin cancer to obesity and diabetes. She currently works on developing and marketing disruptive new technologies in the biotechnology industry. Her areas of interest include innovation in molecular diagnostics, cell therapies, and immunology. She actively participates in various science communication and public engagement initiatives to promote STEM in the community.
You May Also Like
OCT 06, 2020
Immunology
COVID Triggers Abnormalities in Immune Monocytes
OCT 06, 2020
COVID Triggers Abnormalities in Immune Monocytes
University of Manchester immunologists are the first to make an interesting observation about the white blood cells of p ...
OCT 05, 2020
Immunology
Can't Shed Those Extra Pounds? An Inflammatory Gene Could Be to Blame.
OCT 05, 2020
Can't Shed Those Extra Pounds? An Inflammatory Gene Could Be to Blame.
  Australian scientists have zeroed in on a gene linked to an increased obesity risk: a regulator of inflammation c ...
OCT 12, 2020
Drug Discovery & Development
Researchers Solve Key Problem for Cancer Immunotherapy
OCT 12, 2020
Researchers Solve Key Problem for Cancer Immunotherapy
Cancer immunotherapies are becoming increasingly promising as a standard-of-care treatment. However, despite their promi ...
NOV 16, 2020
Immunology
Measles Is Back and COVID Isn't Helping
NOV 16, 2020
Measles Is Back and COVID Isn't Helping
Measles is a highly contagious and airborne viral disease. There is no treatment besides supportive care once a person b ...
DEC 27, 2020
Microbiology
A Potential Treatment Approach for Crohn's Disease
DEC 27, 2020
A Potential Treatment Approach for Crohn's Disease
Researchers may have found a way to treat or prevent Crohn's disease, one of the most common forms of inflammatory bowel ...
DEC 28, 2020
Immunology
Inhaling a Puff of Llama Antibodies to Relieve COVID
DEC 28, 2020
Inhaling a Puff of Llama Antibodies to Relieve COVID
Scientists at the National Institutes of Health have identified new antibody-based weapons in the fight against COVID-19 ...
Loading Comments...